Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.
By Margot Mutsch, Weigong Zhou, P. Rhodes, M. Bopp, Robert T. Chen, T. Linder, C. Spyr, R. Steffen. New England Journal of Medicine, 2004
936 citations recorded by the source corpus.
Subfields: Microbiology, Otorhinolaryngology, Surgery
View Paper: https://www.semanticscholar.org/paper/419a598b63a01091e7e28aa1d3f40ef4ca8d7d9a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- C. Vauthier
- P. Couvreur
- Heather J. Whitaker
- C. Paddy Farrington
- Patrick Musonda
- S. Fukuyama
- B. Spiessens
- H. Kiyono
Citations in the corpus
- Tutorial in biostatistics: the self‐controlled case series method (2006, background): “[27] Oral polio vaccine Intussusception Andrews et al.”
- NALT- versus PEYER'S-patch-mediated mucosal immunity (2004, background): “A causal relationship between the intranasally administered inactivatedinfluenza vaccine used in Switzerland and the incidence of Bell's palsy was formally established in a recent case-control study 96 .”
- Nanotechnology: Intelligent Design to Treat Complex Disease (2006, background): “whereas virosome vaccines for parenteral administration could be applied without side effects in vaccination programs against influenza each year (246,274,275).”